ADVFN Logo ADVFN
시장 데이터
뉴스
도구
시장
팔로우

Hot Features

피드 팔로우

Follow Feed 커뮤니티에서 거래자 및 투자자와 연결하세요.

실시간 옵션 플로우

포괄적인 옵션 데이터를 탐색하고 옵션 흐름으로 고급 필터를 사용하세요.

모니터

터미널 모니터로 주식 및 자산 관심 목록을 구성하고 모니터링하세요.
로그인 Premium Icon프리미엄 Help Menu
S&P 500
5,645.17
0.25%
US Tech 100
19,765.20
-0.41%
다우존스 지수
40,747.89
1.33%
Bitcoin
63,606.25
-1.92%
Registration Strip Icon for alerts 실시간 알림, 사용자 정의 포트폴리오 및 시장 동향을 받으려면 등록하세요.
등록
  1. 홈
  2. 인베스팅
  3. 주식
  4. 미국
  5. NASDAQ
  6. Agile Therapeutics Inc (AGRX)

  7. Agile Therapeutics Inc (AGRX) 뉴스

AGRX

Agile Therapeutics (AGRX)

Agile Therapeutics Inc
일자:
정렬 기준:
 검색 관련기사 보기:NASDAQ:AGRX
일자시간출처헤드라인심볼기업
2019/12/2006:05GlobeNewswire Inc.Agile Therapeutics to Present at Biotech Showcase™ 2020 in San FranciscoNASDAQ:AGRXAgile Therapeutics Inc
2019/11/1506:30GlobeNewswire Inc.Agile Therapeutics Announces FDA Extension of Twirla® NDA Review PeriodNASDAQ:AGRXAgile Therapeutics Inc
2019/11/0906:39Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:AGRXAgile Therapeutics Inc
2019/11/0906:35Edgar (US Regulatory)Prospectus Filed Pursuant to Rule 424(b)(5) (424b5)NASDAQ:AGRXAgile Therapeutics Inc
2019/11/0107:31Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:AGRXAgile Therapeutics Inc
2019/11/0105:31Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:AGRXAgile Therapeutics Inc
2019/10/3107:33GlobeNewswire Inc.Agile Therapeutics Announces Favorable Outcome of FDA Advisory Committee Meeting for its Investigational Transdermal Contrace...NASDAQ:AGRXAgile Therapeutics Inc
2019/10/3107:32Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:AGRXAgile Therapeutics Inc
2019/10/3105:31Edgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)NASDAQ:AGRXAgile Therapeutics Inc
2019/10/2821:11Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:AGRXAgile Therapeutics Inc
2019/10/2821:00GlobeNewswire Inc.Agile Therapeutics Reports Third Quarter 2019 Financial ResultsNASDAQ:AGRXAgile Therapeutics Inc
2019/10/2820:33Edgar (US Regulatory)Quarterly Report (10-q)NASDAQ:AGRXAgile Therapeutics Inc
2019/09/0620:30GlobeNewswire Inc.Agile Therapeutics to Present at Upcoming Investor ConferencesNASDAQ:AGRXAgile Therapeutics Inc
2019/08/0905:32Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:AGRXAgile Therapeutics Inc
2019/08/0905:15GlobeNewswire Inc.Agile Therapeutics Announces Full Exercise of Over-Allotment Option by UnderwritersNASDAQ:AGRXAgile Therapeutics Inc
2019/08/0705:46Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:AGRXAgile Therapeutics Inc
2019/08/0705:45Edgar (US Regulatory)Initial Statement of Beneficial Ownership (3)NASDAQ:AGRXAgile Therapeutics Inc
2019/08/0305:51Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:AGRXAgile Therapeutics Inc
2019/08/0305:44Edgar (US Regulatory)Securities Registration: Employee Benefit Plan (s-8)NASDAQ:AGRXAgile Therapeutics Inc
2019/08/0305:41Edgar (US Regulatory)Prospectus Filed Pursuant to Rule 424(b)(5) (424b5)NASDAQ:AGRXAgile Therapeutics Inc
2019/08/0222:05GlobeNewswire Inc.Agile Therapeutics Announces Pricing of $12 Million Underwritten Public Offering of Common StockNASDAQ:AGRXAgile Therapeutics Inc
2019/08/0205:21Edgar (US Regulatory)Prospectus Filed Pursuant to Rule 424(b)(5) (424b5)NASDAQ:AGRXAgile Therapeutics Inc
2019/08/0205:09Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:AGRXAgile Therapeutics Inc
2019/08/0205:01GlobeNewswire Inc.Agile Therapeutics Announces Proposed Underwritten Public Offering of Common StockNASDAQ:AGRXAgile Therapeutics Inc
2019/08/0121:18Edgar (US Regulatory)Quarterly Report (10-q)NASDAQ:AGRXAgile Therapeutics Inc
2019/08/0121:14Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:AGRXAgile Therapeutics Inc
2019/08/0121:00GlobeNewswire Inc.Agile Therapeutics Reports Second Quarter 2019 Financial ResultsNASDAQ:AGRXAgile Therapeutics Inc
2019/07/2306:24Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:AGRXAgile Therapeutics Inc
2019/07/1820:30GlobeNewswire Inc.Agile Therapeutics Appoints Chief Financial OfficerNASDAQ:AGRXAgile Therapeutics Inc
2019/07/1119:06Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:AGRXAgile Therapeutics Inc
 검색 관련기사 보기:NASDAQ:AGRX

최근 히스토리

AQSE
ASPL.GB
Aseana Prop
BIT
UC7KAY
Unicredit Bank
BIT
UC4AZB
Unicredit Bank
BIT
UB5FVN
Unicredit Bank
BIT
W68AR9
UBS
BIT
UC5T03
Unicredit Bank
BIT
FKR
Falck Renewables
NYSE
FRF
The Fortegra
NASDAQ
ESPR
Esperion Therapeutics
OKEX
LDNUSDT
Ludena Protocol
LSE
WWH
Worldwide Healthcare
NASDAQ
IMGN
ImmunoGen
EU
MT
ArcelorMittal
NYSE
CIR
CIRCOR
NASDAQ
CWST
Casella Waste Systems
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

대한민국
회사 소개
사업
Popular
앱 받기
App Store
Google Play

도움 및 지원받기: kr-support@advfn.com

ADVFN 서비스 이용은 ADVFN의 이용약관에 동의하는 것입니다 이용약관

© 2024 ADVFN PLC - 모든 권리 보유